Acute high-altitude illnesses [5]

New England Journal of Medicine

Volumn 369, Issue 17, 2013, Pages 1666-

  Basnyat, Buddha ^a  

^a Mountain Medicine Society of Nepal   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ALTITUDE DISEASE; DISEASE PREDISPOSITION; DRUG EFFICACY; EXERCISE INTENSITY; HIGH RISK POPULATION; HUMAN; LETTER; MARATHON RUNNER; MOUNTAINEERING; PRIORITY JOURNAL; MALE; NOTE;

ACETAZOLAMIDE; ALTITUDE SICKNESS; HUMANS; MALE;

EID: 84886262008     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1309747     Document Type: Letter

References (4)

1. Larson EB, Roach RC, Schoene RB, Hornbein TF. Acute mountain sickness and acetazolamide: clinical efficacy and effect on ventilation. JAMA 1982;248:328-32.
2. van Patot MC, Leadbetter G III, Keyes LE, Maakestad KM, Olson S, Hackett PH. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 2008;9:289-93.
3. Kayser B, Hulsebosch R, Bosch F. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. High Alt Med Biol 2008;9:15-23.
4. Richalet JP, Larmignat P, Poitrine E, Letournel M, Canouï-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med 2012;185:192-8.